Adrenergic receptor [[beta].sub.3] is involved in the memory consolidation process in mice.
Attention and emotion have a positive impact on memory formation, which is related to the activation of the noradrenergic system in the brain (1,2). Norepinephrine (NE), the neurotransmitter synthesized and released by the locus coeruleus in the central nervous system (CNS), binds to the noradrenergic G-protein-coupled receptors [alpha]1, [alpha]2, b1, b2, and [[beta].sub.3] that activate distinct pathways depending on the receptor subtype (3). The hippocampus and amygdala are critical for memory formation and consolidation, a process that is modulated by the noradrenergic system (4). Indeed, the hippocampus and amygdala express [beta]-adrenoceptor subtypes and receive noradrenergic projections from the locus coeruleus that critically regulate behavioral memory in rodents (4,5). [beta]-adrenoceptors ([beta]-AR) are key for the processing of memories (6). The pharmacological blockage of [beta]-AR with propranolol has been shown to impair the ability of rats and humans to form and consolidate long-term memory (7,8). This effect can be explained by the fact that the amygdala and hippocampus are activated during the process of acquisition and retrieval of emotional memories. Also, [beta]-AR are expressed in both structures and propranolol blocks the increase in activity of the amygdala and hippocampus in humans after an emotional stimulus (9).
Several mechanisms have been proposed to explain the role of norepinephrine in long-term memory in mammals. Long-term potentiation (LTP), a proposed mechanism behind memory and learning, is modulated by NE acting on [beta]-AR to enhance LTP and boost memory endurance (3,10,11). Additionally, [beta]-AR activation increases the expression of the a-amino-3-hydroxy-5-methyl-4-isoxazoleproprionic acid (AMPA) receptor subunit GluA1, one of the four subunits of the AMPA receptor for glutamate (12). NE also increases memory consolidation through an increase in glucose availability in the hippocampal neurons as shown by studies performed in chickens with zinterol and CL316243, a [[beta].sub.2]-AR agonist and a [[beta].sub.3]-AR agonist, respectively (13). This occurs through the increased breakdown of glycogen by phosphorylase glycogen brain (PYGB) activation in response to [[beta].sub.2]-AR activation, while [[beta].sub.3]-AR mediates the glucose uptake by the glucose transporter type 3 (GLUT3). These studies suggested that [[beta].sub.3]-AR increases glucose uptake in an early stage, whereas the [[beta].sub.2]-AR increases glucose availability at a later stage, suggesting a synergic effect of both adrenoceptors in regulating short- and long-term memory, respectively.
To better understand the mechanisms underlying the role of the [[beta].sub.3]-AR in learning, the memory in knockout mice for this receptor ([[beta].sub.3]-ARKO) was evaluated. Thus, we employed two behavioral models related to declarative memory, novel object recognition (14), and social preference and discrimination tests (15). In addition, emotionality and motor aspects in these mice were investigated by the open field and elevated plus maze tasks, since motor impairments and anxiety could interfere with the learning performance in learning models. Our study shows for the first time that [[beta].sub.3]-AR plays a role in short- and long-term memory and suggests that it could be related to GLUT3 expression.
Material and Methods
[[beta].sub.3]-ARKO mice, generated by removing the 306 bp genomic fragment containing the sequences encoding the third through the fifth transmembrane domains of the [[beta].sub.3]-AR and replacing it with a neomycin selection cassette as described by Susulic et al. (16), were obtained from Jackson Laboratory (Bar Harbor, USA). All animals were genotyped to confirm their status as homozygous knockout or wild-type (WT). Homozygous [[beta].sub.3]-ARKO mice are unresponsive to [[beta].sub.3]-AR agonist treatment. All animals were maintained on an FVB background. Approximately 60-day-old male [[beta].sub.3]-ARKO mice and WT controls were used following the animal protocol approved by the Institutional Committee on Animal Research at the Center of Biological Sciences and Health, Mackenzie Presbyterian University. Each experiment was repeated two or three times on different sets of animals (n=8). Mice were housed in groups under standard conditions at 26[degrees] C, 55-60% humidity, and a 12-h light/dark cycle with ad libitum access to standard food (Nuvilab, Brazil) and water.
Open Field. The open field test (OFT) was used for assessment of locomotor and exploratory activity of the mice (17). The apparatus was located in a 1.8 x 4.6 m test room and lit by a 15-lux lamp for background lighting; the apparatus was washed with a 5% alcohol-water solution before placement of the animals to obviate bias caused by odor cues left by previous animals. The animals were tested in a square acrylic arena (72 x 72 cm) surrounded by a 30-cm wall. The floor of the arena was divided into sixteen 18 x 18 cm squares, and mice were placed into the center of the arena and observed for 5 min; all tests were recorded by video camera for later analysis. The following parameters were measured: 1) total locomotion (total number of lines crossed with four paws); 2) grooming (number of times cleaning the body with paws, grooming the body and pubis with the mouth, and face washing, and 3) rearing (number of times the rodents stood on their hind legs).
Elevated Plus Maze (EPM). The EPM was made of plastic covered plywood and consisted of two opposed open arms (30 x 5 cm) and two opposed enclosed arms (30 x 5 x 15 cm) connected by a central open square (5 x 5 cm) (17). The maze was elevated 38 cm above the floor and placed inside a room free from noise and disturbances, under dim laboratory light and the test was recorded by video camera for later analysis. The animals were placed into the central square of the maze facing one of the open arms and observed for 5 min. The percentage of time spent on the center and on open and closed arms (arm entry = all four paws on an arm) and number of head-dips (exploratory movement of head/shoulders over the side of the maze) were evaluated (18).
Novel object recognition. For assessment of novel object recognition, the animals were placed in the open field apparatus used to assess their locomotor activity so the environment would not be new to them. The objects used during testing were Lego[R] figures of equal size and material that differed in design. These were weighted to minimize the movement of the objects by the mice during the trials. The trials were video-recorded and later coded by an experimenter who was blind to the treatment groups. The objects to be used were first assessed to ensure that there were neither intrinsic preferences nor aversions, and that each object would be explored for similar durations upon initial exposure. Exploration was considered when the mice directed the nose to the object at a distance of no more than 2 cm and/or touching the object with the nose or mouth. Rearing up on the object was counted only if facing toward, but not away from the object (19,20). Total time spent exploring each object was recorded over a 5-min period. At the end of the first trial, the mice were returned to their home cage for 3 h. Afterwards, each mouse was returned to the same testing cage for the second trial, which contained one of the previous objects (a familiar object) and a novel object, placed in the same locations. The total time spent exploring each object was recorded over a 5-min period. At the end of the second trial, the animals were returned to their home cage for 24 h. Then, each mouse was returned to the same testing cage for the third trial, which contained the same familiar object and another novel object, placed in the same locations.
Social preference and discrimination. The parameters were evaluated using a non-automated 3-chamber box with three successive and identical chambers (Stoelting, Ireland) as described previously (21-23). During habituation, the mice explored the three chambers freely for 10 min from the intermediate compartment, with the two other chambers containing empty wire cages. In the second phase, to test social preference, the mouse was placed in the central box, while an unknown mouse (stranger 1) was in one of the wire cages in a random and balanced manner and the mouse was allowed to explore the three chambers for 10 min. The time spent in each of the chambers, the number of entries into each chamber, and the time spent sniffing each wire cage were recorded. In the third phase, social memory was evaluated with a new unknown mouse (stranger 2) in the remaining empty wire cage, with the mouse allowed to explore the entire arena for 6 min. The time spent with the previously investigated mouse (stranger 1) and the novel unknown mouse (stranger 2) and the same measures were recorded for the social preference evaluation.
Gene expression analysis
mRNA. Total tissue RNA was extracted from the hippocampus and amygdala using the RNeasy[R] Plus Universal Mini Kit (Qiagen, USA), following the manufacturer's instructions. RNA was quantified with a NanoDrop spectrophotometer, and 0.5-1.0 mg total RNA was used to produce cDNA using the SuperScript[R] III First-Strand Synthesis SuperMix for qRT-PCR (Invitrogen, USA). RTqPCR was performed as previously described (24). Genes of interest (sequences upon request) were measured (Ste[beta]-one Applied Biosystem, USA) using QuantiTect[TM] SYBR[R] Green (Qiagen, USA). The melting curve protocol was performed to verify the specificity of the amplicon generation. Standard curves consisted of 4-5 points of serially diluted mixed experimental and control group cDNA. Cyclophilin A (CycloA) was used as a housekeeping internal control gene. The coefficient of correlation was greater than 0.99 for all curves, and the amplification efficiency ranged between 80 and 110%. Results were reported as the ratio of test mRNA to CycloA mRNA. The following genes were studied: b1 adrenergic receptor (Adrbl), b2 adrenergic receptor (Adrb2), glucose transporter 3 (Slc2a3), phosphorylase glycogen b (Pygb), brain-derived neurotrophic factor (Bdnf), and nerve growth factor (Ngf).
All data are reported as means [+ or -] SEM and were analyzed using PRISM software (GraphPad Software, USA). Student's t-test was used to compare the groups WT and [[beta].sub.3]-ARKO. P < 0.05 was used to reject the null hypothesis.
[[beta].sub.3]-ARKO mice exhibited impairment in short- and long-term memory
To evaluate if the absence of this adrenoceptor would impact their ambulatory and exploratory activity, [[beta].sub.3]-ARKO mice were exposed to the open field under conditions of low light intensity, which sets a low emotionality context. No differences in line crossing and grooming were detected, but an increase in rearing was observed in the [[beta].sub.3]-ARKO mice (P<0.02 and t= 2.82) (Figure 1A, B, and C).
Next, the animals were studied in the elevated plus maze to assess anxiety (17). No difference was observed in the time spent in the center, open, or closed arms (Figure 1D, E, and F) and in the number of head-dips (Figure 1G).
Animals were then tested for cognition using the novel object recognition task. In the training phase, both groups spent a similar amount of time with both objects 01 and 01' (Figure 2A). When the mice were presented with a new object (02) 3 h later, WT mice spent 3-fold more time with the new object (02) than with the familiar object (01) (P< 0.001, F=8.795). However, the [[beta].sub.3]-ARKO mice spent an equal amount of time with the familiar object (01) as with the novel object (02) (Figure 2B). Similar results were obtained when the mice were presented 24 h later to another new object (03); WT mice spent 2.5-fold more time with the new object than the familiar object (01) (P<0.05, F=3.982) while [[beta].sub.3]-ARKO mice spent an equal amount of time with both (Figure 2C) (17).
In the social discrimination test, [[beta].sub.3]-ARKO mice were tested regarding their ability to discriminate strangers from familiar conspecifics. In the first phase of the test, both groups explored all the compartment of the apparatus equally (data not shown). In the third phase, the mice were presented to familiar and unfamiliar conspecifics. The WT mice presented a significant preference for the newly introduced mouse compared to the familiar animal (P< 0.001, F=11.86), whereas [[beta].sub.3]-ARKO mice did not show this discrimination (Figure 3).
Decreased Slc2a3 expression in the amygdala but not in the hippocampus of [[beta].sub.3]-ARKO mice
We first evaluated if the lack of [[beta].sub.3]-AR would lead to an increase in the Adrbl and Adrb2 mRNA expression as a compensatory mechanism. The mRNA levels of Adrbl were the same in the hippocampus and amygdala of p3ARKO mice compared to WT, but there was a significant increase in mRNA levels of Adrb2 mRNA in the hippocampus of the [[beta].sub.3]-ARKO mice compared to WT (P<0.01, t=3.85) (Figure 4A and D).
To understand the mechanisms underlying the lack of memory and social recognition, RT-qPCR was used to measure mRNA levels of neurotrophins and of proteins involved in glucose metabolism in the hippocampus and amygdala. No difference was found for Slc2a3, Pygb, Bdnf, and Ngf mRNA levels in the hippocampus (Figure 4A to C). However, we found a decrease in Slc2a3 mRNA (P<0.03, t=2.902) and an increase in Ngf mRNA levels in the amygdala (P<0.03, t=3.033) (Figure 4E and F).
Our results showed for the first time that [[beta].sub.3]-AR is relevant for declarative memory acquisition and consolidation, since its absence in mice significantly impaired these processes despite an overexpression of Adrb2 in the hippocampus. We also showed that this could be due to the decreased gene expression of Slc2a3 in the amygdala. Motor impairments or anxiety-like behaviors were not involved in the lack of memory acquisition and social recognition in [[beta].sub.3]-ARKO mice.
Studies performed in chicks using pharmacological approaches have suggested that both the [[beta].sub.2]-AR and [[beta].sub.3]-AR receptors are important in the process of the acquisition of declarative memory (25). Memory acquisition and consolidation mediated by [beta]-ARs involve the activation of the glucose metabolism (26). Norepinephrine leads to increased GLUT3 expression in the membrane of neurons through the activation of [[beta].sub.3]-AR, while activation of [[beta].sub.2]-AR leads to increased activity of the PYGB. The combined action of the two isoforms results in an increase in the glucose available to be used by the hippocampal neurons. Therefore, the NE effect would depend on the presence and concomitant activation of both [[beta].sub.2]-AR and [[beta].sub.3]-AR receptors and that the activation of [[beta].sub.2]-AR would be sufficient for the acquisition of memory during the blocking of [[beta].sub.3]-AR (13). However, our results contradicted these findings, as they showed that even in the presence of an increase in [[beta].sub.2]-AR gene expression, memory consolidation and social recognition were impaired in [[beta].sub.3]-ARKO mice.
We also showed that in the absence of the [[beta].sub.3]-AR there was a significant decrease in gene expression of Slc2a3 in the amygdala, but not in the expression of Pygb. It is surprising, however, that there was impaired memory formation despite normal levels of mRNA for Pygb, suggesting that GLUT3 was critical to this process. Although the literature shows that the activation of PYGB is key to memory formation, our results showed that the impairment of memory formation occurred even in the presence of normal mRNA levels for this enzyme.
It has been shown that norepinephrine significantly increases in the frontal cortex and hypothalamus of rats exposed to new settings and an unfamiliar rat, mediating long-term memory formation (27), suggesting that NE is important in mediating the response to novel stimulus. The increase in NE levels leads to an increase in excitability of neurons from hippocampus via activation of [beta]-AR (28-30).
[[beta].sub.3]-AR are highly expressed in the subgranular zone of the dentate gyrus (DG) during development (31). Also, there is a very dense innervation to DG originating from LC with consequent higher levels of NA in DG compared with CA1 and CA3 regions (32). Taken together, these data could explain why the lack of [[beta].sub.3]-AR in [[beta].sub.3]-ARKO mice results in a significant impairment in memory consolidation.
In our model, memory formation impairment was not related to BDNF and NGF, classically known neurotrophin mediators of synaptic plasticity (33,34). In fact, there was an increased expression of Ngf in the amygdala of the [[beta].sub.3]-ARKO mice, which was not able to restore the memory acquisition capacity.
Although social recognition, a process that involves the amygdala (35,36), was significantly impaired in the p3ARKO mice, the total contact time between [[beta].sub.3]-ARKO and known and unknown animals was equal to that of the WT mice, suggesting that there was no impairment to social interaction (37,38).
We observed that [[beta].sub.3]-ARKO animals did not show anxious behavior. These results are surprising considering that the locus coeruleus sends projections to the amygdala, the structure of the limbic system responsible for the recognition and mediation of fear and anxiety. Moreover, the use of selective [[beta].sub.3]-AR agonists induces a significant anxiolytic-like effect when administered orally to mice (39,40).
Taken together, our data showed that [[beta].sub.3]-AR receptors were involved in declarative memory consolidation.
(1.) Harley C. Noradrenergic and locus coeruleus modulation of the perforant path-evoked potential in rat dentate gyrus supports a role for the locus coeruleus in attentional and memorial processes. Prog Brain Res 1991; 88: 307-321, doi: 10.1016/S0079-6123(08)63818-2.
(2.) Bouret S, Sara SJ. Network reset: a simplified overarching theory of locus coeruleus noradrenaline function. Trends Neurosci 2005; 28: 574-582, doi: 10.1016/j.tins.2005.09.002.
(3.) Gelinas JN, Banko JL, Hou L, Sonenberg N, Weeber EJ, Klann E, et al. J Biol Chem 2007; 282: 27527-27535, doi: 10.1074/jbc.M701077200.
(4.) Sara SJ. The locus coeruleus and noradrenergic modulation of cognition. Nat Rev Neurosci 2009; 10: 211-223, doi: 10.1038/nrn2573.
(5.) Berridge CW, Waterhouse BD. The locus coeruleus-noradrenergic system: modulation of behavioral state and state-dependent cognitive processes. Brain Res Brain Res Rev 2003. 42: 33-84, doi: 10.1016/S0165-0173(03)00143-7.
(6.) Stanton PK, Mody I, Heinemann U. A role for N-methyl-Daspartate receptors in norepinephrine-induced long-lasting potentiation in the dentate gyrus. Exp Brain Res 1989; 77: 517-530, doi: 10.1007/BF00249605.
(7.) Cahill L, Pham CA, Setlow B. Impaired memory consolidation in rats produced with beta-adrenergic blockade. Neurobiol Learn Mem 2000; 74: 259-266, doi: 10.1006/ nlme.1999.3950.
(8.) Lonergan MH, Olivera-Figueroa LA, Pitman RK, Brunet A. Propranolol's effects on the consolidation and reconsolidation of long-term emotional memory in healthy participants: a meta-analysis. J Psychiatry Neurosci 2013; 38: 222-231, doi: 10.1503/jpn.120111.
(9.) Strange BA, Dolan RJ. Beta-adrenergic modulation of emotional memory-evoked human amygdala and hippocampal responses. Proc Natl Acad Sci USA 2004; 101: 11454-11458, doi: 10.1073/pnas.0404282101.
(10.) Maity S, Jarome TJ, Blair J, Lubin FD, Nguyen PV. Noradrenaline goes nuclear: epigenetic modifications during long-lasting synaptic potentiation triggered by activation of beta-adrenergic receptors. J Physiol 2016; 594: 863-881, doi: 10.1113/JP271432.
(11.) Hopkins WF, Johnston D. Frequency-dependent noradrenergic modulation of long-term potentiation in the hippocampus. Science 1984; 226: 350-352, doi: 10.1126/science. 6091272.
(12.) Hu H, Real E, Takamiya K, Kang MG, Ledoux J, Huganir RL, etal. Cell2007; 131: 160-173, doi: 10.1016/j.cell.2007.09.017.
(13.) Gibbs ME, Summers RJ. Separate roles for beta2- and beta3-adrenoceptors in memory consolidation. Neuroscience 2000; 95: 913-922, doi: 10.1016/S0306-4522(99)00469-8.
(14.) Antunes M, Biala G. The novel object recognition memory: neurobiology, test procedure, and its modifications. Cogn Process 2012; 13: 93-110, doi: 10.1007/s10339-011-0430-z.
(15.) Engelmann M, Hadicke J, Noack J. Testing declarative memory in laboratory rats and mice using the nonconditioned social discrimination procedure. Nat Protoc 2011; 6: 1152-1162, doi: 10.1038/nprot.2011.353.
(16.) Susulic VS, Frederich RC, Lawitts J, Tozzo E, Kahn BB, Harper ME, et al. Targeted disruption of the beta 3-adrenergic receptor gene. J Biol Chem 1995; 270: 29483-29492, doi: 10.1074/jbc.270.49.29483.
(17.) Hunsberger J, Duman C. Animal models for depression-like and anxiety-like behavior. 2007. Protocol Exchange 2007, doi: 10.1038/nprot.2007.542.
(18.) Venero C, Guadano-Ferraz A, Herrero AI, Nordstrom K, Manzano J, de Escobar GM, et al. Anxiety, memory impairment, and locomotor dysfunction caused by a mutant thyroid hormone receptor alpha1 can be ameliorated by T3 treatment. Genes Dev 2005; 19: 2152-2163, doi: 10.1101/ gad.346105.
(19.) Sik A, van Nieuwehuyzen P, Prickaerts J, Blokland A. Performance of different mouse strains in an object recognition task. BehavBrain Res 2003; 147:49-54, doi: 10.1016/S0166-4328 (03)00117-7.
(20.) Mathiasen JR, DiCamillo A. Novel object recognition in the rat: a facile assay for cognitive function. Curr Protoc Pharmacol 2010; Chapter 5: Unit 5.59.
(21.) Moy SS, Nadler JJ, Perez A, Barbaro RP, Johns JM, Magnuson TR, et al. Sociability and preference for social novelty in five inbred strains: an approach to assess autistic-like behavior in mice. Genes Brain Behav 2004; 3: 287-302, doi: 10.1111/j.1601-1848.2004.00076.x.
(22.) Moy SS, Nadler JJ, Young NB, Nonneman RJ, Segall SK, Andrade GM, et al. Social approach and repetitive behavior in eleven inbred mouse strains. Behav Brain Res 2008; 191: 118-129, doi: 10.1016/j.bbr.2008.03.015.
(23.) Duchon A, Pothion S, Brault V, Sharp AJ, Tybulewicz VL, Fisher EM, et al. The telomeric part of the human chromosome 21 from Cstb to Prmt2 is not necessary for the locomotor and short-term memory deficits observed in the Tc1 mouse model of Down syndrome. Behav Brain Res 2011; 217: 271-81, doi: 10.1016/j.bbr.2010.10.023.
(24.) Castillo M, Hall JA, Correa-Medina M, Ueta C, Won Kang H, Cohen DE, et al. Disruption of thyroid hormone activation in type 2 deiodinase knockout mice causes obesity with glucose intolerance and liver steatosis only at thermoneutrality. Diabetes 2011; 60: 1082-1089, doi: 10.2337/db100758.
(25.) Gibbs ME, Hutchinson DS, Summers RJ. Role of beta-adrenoceptors in memory consolidation: beta3-adrenoceptors act on glucose uptake and beta2-adrenoceptors on glycogenolysis. Neuropsychopharmacology 2008; 33: 2384-2397, doi: 10.1038/sj.npp.1301629.
(26.) Messier C. Glucose improvement of memory: a review. Eur J Pharmacol 2004; 490: 33-57, doi: 10.1016/j.ejphar. 2004.02.043.
(27.) McQuade R, Creton D, Stanford SC. Effect of novel environmental stimuli on rat behaviour and central noradrenaline function measured by in vivo microdialysis. Psychopharmacology (Berl) 1999; 145: 393-400.
(28.) Lacaille JC, Harley CW. The action of norepinephrine in the dentate gyrus: beta-mediated facilitation of evoked potentials in vitro. Brain Res 1985; 358: 210-220, doi: 10.1016/ 0006-8993(85)90965-5.
(29.) Stanton PK, Sarvey JM. Depletion of norepinephrine, but not serotonin, reduces long-term potentiation in the dentate gyrus of rat hippocampal slices. J Neurosci 1985; 5: 2169-2176, doi: 10.1523/JNEUROSCI.05-08-02169.1985.
(30.) Heginbotham LR, Dunwiddie TV. Long-term increases in the evoked population spike in the CA1 region of rat hippocampus induced by beta-adrenergic receptor activation. J Neurosci 1991; 11: 2519-2527, doi: 10.1523/JNEUROSCI.11-08-02519.1991.
(31.) Jhaveri DJ, Mackay EW, Hamlin AS, Marathe SV, Nandam LS, Vaidya VA, et al. Norepinephrine directly activates adult hippocampal precursors via beta3-adrenergic receptors. J Neurosci 2010; 30: 2795-2806, doi: 10.1523/JNEUROSCI.3780-09.2010.
(32.) Loy R, Koziell DA, Lindsey JD, Moore RY. Noradrenergic innervation of the adult rat hippocampal formation. J Comp Neurol 1980; 189: 699-710, doi: 10.1002/cne.901890406.
(33.) Woo NH, Teng HK, Siao CJ, Chiaruttini C, Pang PT, Milner TA, et al. Activation of p75NTR by proBDNF facilitates hippocampal long-term depression. Nat Neurosci 2005; 8: 1069-1077, doi: 10.1038/nn1510.
(34.) Schliebs R, Arendt T. The cholinergic system in aging and neuronal degeneration. Behav Brain Res 2010; 221: 555563, doi: 10.1016/j.bbr.2010.11.058.
(35.) Adolphs R, Cahill L, Schul R, Babinsky R. Impaired declarative memory for emotional material following bilateral amygdala damage in humans. Learn Mem 1997; 4: 291-300, doi: 10.1101/lm.4.3.291.
(36.) Maaswinkel H, Baars AM, Gispen WH, Spruijt BM. Roles of the basolateral amygdala and hippocampus in social recognition in rats. Physiol Behav 1996; 60: 55-63, doi: 10.1016/0031-9384(95)02233-3.
(37.) Chen CC, Williams CL. Interactions between epinephrine, ascending vagal fibers, and central noradrenergic systems in modulating memory for emotionally arousing events. Front Behav Neurosci 2012; 6: 35.
(38.) Miyashita T, Williams CL. Peripheral arousal-related hormones modulate norepinephrine release in the hippocampus via influences on brainstem nuclei. Behav Brain Res 2004; 153: 87-95, doi: 10.1016/j.bbr.2003.11.005.
(39.) Stemmelin J, Cohen C, Terranova JP, Lopez-Grancha M, Pichat P, Bergis O, et al. Stimulation of the beta3-Adrenoceptor as a novel treatment strategy for anxiety and depressive disorders. Neuropsychopharmacology 2008; 33: 574-587, doi: 10.1038/sj.npp.1301424.
(40.) Butler TR, Chappell AM, Weiner JL. Effect of beta3 adrenoceptor activation in the basolateral amygdala on ethanol seeking behaviors. Psychopharmacology (Berl) 2014; 231: 293-303.
P. Souza-Braga , F.B. Lorena [1,2], B.P.P. Nascimento [1,2], C.P. Marcelino [1,2], T.T. Ravache , E. Ricci , M.M. Bernardi  and M.O. Ribeiro 
 Programa de Pos-Graduacao em Disturbios do Desenvolvimento, Centro de Ciencias Biologicas e da Saude, Universidade Presbiteriana Mackenzie, Sao Paulo, SP, Brasil
 Programa de Pos-Graduacao em Medicina Translacional, Departamento de Medicina, Escola Paulista de Medicina, Universidade Federal de Sao Paulo, Sao Paulo, SP, Brasil
 Programa de Pos-Graduacao em Patologia Ambiental e Experimental, Universidade Paulista, Sao Paulo, SP, Brasil
Correspondence: M.O. Ribeiro: <email@example.com>
Received October 8, 2017 | Accepted June 4, 2018
Caption: Figure 1. Loss of [[beta].sub.3]-AR does not affect locomotor activity or anxiety behavior in mice. A-C, Open field: A, Total number of line crossings; B, Total number of groomings; C, Total number of rearings. D-G, Elevated plus maze: D, Time spent in center of apparatus; E, Time spent in open arms; F, Time spent in closed arms; G, Total number of head-dips. *P<0.02 vs wild-type (WT). Data are reported as means [+ or -]SEM (n=10) (Student's t-test).
Caption: Figure 2. [[beta].sub.3]-AR is involved in memory consolidation. A, Wild-type (WT) and [[beta].sub.3]-ARKO mice spent the same amount of time with a familiar object (O1) and a similar object (O10) during object familiarization. B, Three hours after object familiarization, WT mice spent significantly more time with a novel object (O2) than a familiar object (O1) during object recognition, while [[beta].sub.3]-ARKO mice spent an equal amount of time with both O1 and O2. C, Twenty-four hours after object familiarization, WT mice spent significantly more time with a novel object (O3) than a familiar object (O1) during object recognition, while [[beta].sub.3]-ARKO mice spent an equal amount of time with both O1 and O3. Data are reported as means [+ or -] SE (n=10). *P<0.01, **P<0.05 vs WT (ANOVA followed by the Student Newman-Keuls test).
Caption: Figure 3. [[beta].sub.3]-AR is important for social discrimination. Wild-type (WT) mice showed normal preference for social novelty and spent significantly more time in the chamber with the novel mouse than in the chamber with the familiar mouse. [[beta].sub.3]-ARKO spent the same amount of time with the familiar mouse and with the novel mouse. Data are reported as means[+ or -]SE (n=10). *P<0.001 (ANOVA followed by the Student Newman-Keuls test).
Figure 4. Gene expression (mRNA levels) in the hippocampus (A-C) and in the amygdala (D-F) of wild-type (WT) and [[beta].sub.3]-ARKO mice measured by RT-qPCR and using CycloA as internal control. Data are reported as means [+ or -] SE (n=4). *P<0.001, **P<0.03 (Student's t-test).
|Printer friendly Cite/link Email Feedback|
|Title Annotation:||Research Article|
|Author:||Souza-Braga, P.; Lorena, F.B.; Nascimento, B.P.P.; Marcelino, C.P.; Ravache, T.T.; Ricci, E.; Bernar|
|Publication:||Brazilian Journal of Medical and Biological Research|
|Date:||Oct 1, 2018|
|Previous Article:||Comparison of endoplasmic reticulum stress and mitochondrial biogenesis responses after 12 weeks of treadmill running and ladder climbing exercises...|
|Next Article:||Saquinavir plus methylprednisolone ameliorates experimental acute lung injury.|